Citation

O'Shea LE, Dickens GL. Compr. Psychiatry 2015; 62: 132-140.

Affiliation

St Andrew's Academic Department, w, Northampton, NN1 5DG, United Kingdom; School of Social and Health Sciences, Abertay University, Bell Street, Dundee, DD1 1HG, United Kingdom. Electronic address: g.dickens@abertay.ac.uk.

Copyright

(Copyright © 2015, Elsevier Publishing)

DOI

10.1016/j.comppsych.2015.07.009

PMID

26343477

Abstract

OBJECTIVE: Periodic structured violence risk assessment is the principle method underlying treatment planning for mentally disordered offenders but little is known about how risk changes over time. We aimed to determine whether hospitalised patients underwent reliable clinical change in assessed risk.

METHOD: We used a pseudo-prospective longitudinal study design. Demographic, clinical and risk assessment data of adult inpatients (N=480) who had been routinely assessed with the HCR-20 on two to four occasions over a mean period of 17 months (SD=2) were collated. Linear mixed models regression was conducted to determine change over time on total, subscale, and individual item scores, and relative change between clinical and demographic groups. The Reliable Change Index was calculated to examine whether change was greater than that expected by measurement error; clinically significant change was defined as the extent to which HCR-20 scores reduced below previously reported scores for patients not requiring hospitalisation.

RESULTS: HCR-20 total score (Estimate -0.42, 95% CI=-0.84, -0.01, p<.05; d=.20) and clinical score (Estimate=-0.42, 95% CI=-0.64, -0.20, p<.001; d=.36) reduced over assessments. Significant differences in change were evident between clinically and demographically defined groups. A maximum of 3% of individuals showed clinically significant reliable reductions in HCR-20 total scores. The scores of patients whose overall level of risk was judged to have decreased did not reduce between assessments.

CONCLUSION: Violence risk changes very little over the course of treatment although there is some variation between groups. Most change cannot be demonstrated to be reliable or clinically significant. Important clinical management decisions should not depend solely on evidence from changes in HCR-20 risk assessment.

Language: en